1. Home
  2. HLLY vs BCYC Comparison

HLLY vs BCYC Comparison

Compare HLLY & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Holley Inc.

HLLY

Holley Inc.

HOLD

Current Price

$4.11

Market Cap

493.2M

ML Signal

HOLD

Logo Bicycle Therapeutics plc

BCYC

Bicycle Therapeutics plc

HOLD

Current Price

$7.01

Market Cap

476.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLLY
BCYC
Founded
1903
2009
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
493.2M
476.6M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
HLLY
BCYC
Price
$4.11
$7.01
Analyst Decision
Strong Buy
Buy
Analyst Count
7
11
Target Price
$4.43
$18.73
AVG Volume (30 Days)
701.9K
237.4K
Earning Date
03-10-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$598,132,000.00
$28,339,000.00
Revenue This Year
$1.75
N/A
Revenue Next Year
$5.07
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.60
$6.03
52 Week High
$4.43
$13.66

Technical Indicators

Market Signals
Indicator
HLLY
BCYC
Relative Strength Index (RSI) 47.70 53.83
Support Level $4.03 $6.37
Resistance Level $4.27 $7.34
Average True Range (ATR) 0.17 0.33
MACD -0.02 0.06
Stochastic Oscillator 40.82 68.27

Price Performance

Historical Comparison
HLLY
BCYC

About HLLY Holley Inc.

Holley Inc is a designer, marketer, and manufacturer of high-performance automotive aftermarket products, featuring a portfolio of iconic brands serving the car and truck industry. It offers a diversified line of performance automotive products including fuel injection systems, tuners, exhaust products, carburetors, safety equipment and various other performance automotive products. The Company's products are designed to enhance street, off-road, recreational and competitive vehicle performance through increased horsepower, torque and drivability. The company's brands include Holley, APR, MSD and Flowmaster, among others. It derives revenue from the U.S. and Italy, of which prime revenue is derived from the U.S.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

Share on Social Networks: